-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RhyAzIlthOHfssKGc/8MZLjQ10krjVQtCZCEi66/A+EwcRIGwDsY+nsnaCdVZARa ZK9U6qCXot+84BsuqY0Z9w== 0000914190-01-000033.txt : 20010223 0000914190-01-000033.hdr.sgml : 20010223 ACCESSION NUMBER: 0000914190-01-000033 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20010214 GROUP MEMBERS: MEDTRONIC ASSET MANAGEMENT, INC. GROUP MEMBERS: MEDTRONIC INC SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BIONEBRASKA INC CENTRAL INDEX KEY: 0000910133 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 470727668 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-60371 FILM NUMBER: 1540613 BUSINESS ADDRESS: STREET 1: 3820 NW 46TH STREET CITY: LINCOLN STATE: NE ZIP: 68524-1637 BUSINESS PHONE: 8007862580 MAIL ADDRESS: STREET 1: 3820 NW 46TH STREET CITY: LINCOLN STATE: NE ZIP: 68524-1637 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MEDTRONIC INC CENTRAL INDEX KEY: 0000064670 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 410793183 STATE OF INCORPORATION: MN FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 7000 CENTRAL AVE NE STREET 2: MS 316 CITY: MINNEAPOLIS STATE: MN ZIP: 55432 BUSINESS PHONE: 6125744000 SC 13G 1 0001.txt SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ___)* BioNebraska, Inc. (Name of Issuer) Common Stock, $.01 par value (Title of Class of Securities) 09061V 10 8 (CUSIP Number) August 7, 2000 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [ x ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 7 Pages SCHEDULE 13G CUSIP No. 09061V 10 8 Page 2 of 7 Pages 1 NAMES OF REPORTING PERSONS/ I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Medtronic , Inc. (41-0793183) 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)** (a) [ ] (b) [ ] **Joint Filing 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Minnesota NUMBER OF 5 SOLE VOTING POWER 846,518 (includes 645,161 shares which SHARES may be acquired upon conversion of preferred stock) BENEFICIALLY OWNED BY 6 SHARED VOTING POWER EACH REPORTING 7 SOLE DISPOSITIVE POWER 846,528 (includes 645,161 shares PERSON which may be acquired upon conversion of preferred stock) WITH 8 SHARED DISPOSITIVE POWER 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 846,528 (includes 645,161 shares which may be acquired upon conversion of preferred stock) 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES SEE INSTRUCTIONS) [ ] 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 10.7% 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO SCHEDULE 13G CUSIP No. 09061V 10 8 Page 3 of 7 Pages 1 NAMES OF REPORTING PERSONS/I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Medtronic Asset Management, Inc. (41-1721127) 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) ** (a) [ ] (b) [ ] **Joint Filing 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Minnesota NUMBER OF 5 SOLE VOTING POWER 846,518 (includes 645,161 shares which SHARES may be acquired upon conversion of preferred stock) BENEFICIALLY OWNED BY 6 SHARED VOTING POWER EACH REPORTING 7 SOLE DISPOSITIVE POWER 846,518 (includes 645,161 shares PERSON which may be acquired upon conversion of preferred stock) WITH 8 SHARED DISPOSITIVE POWER 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 846,518 (includes 645,161 shares which may be acquired upon conversion of preferred stock) 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] 10.7% 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO Answer every item. If an item is inapplicable or the answer is in the negative, so state. Item 1(a) Name of Issuer: BioNebraska, Inc. Item 1(b) Address of Issuer's Principal Executive Offices: 3820 NW 46th Street Lincoln, Nebraska 68542 Item 2(a) Name of Person Filing: See Cover Pages, Item 1 Item 2(b) Address of Principal Business Office or, if none, residence: 710 Medtronic Parkway NE Minneapolis, Minnesota 55432 Item 2(c) Citizenship: See Cover Pages, Item 4 Item 2(d) Title of Class of Securities: Common Stock, $.01 par value Item 2(e) CUSIP No.: See Cover Pages Item 3 If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: (a) [ ] Broker or dealer registered under Section 15 of the Exchange Act. (b) [ ] Bank as defined in Section 3(a)(b) of the Exchange Act. (c) [ ] Insurance company as defined in Section 3(a)(19) of the Exchange Act. (d) [ ] Investment company registered under Section 8 of the Investment Company Act. (e) [ ] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E). (f) [ ] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F). (g) [ ] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G). (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act. (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act. (j) [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(J). If this statement is filed pursuant to Rule 13d-1(c), check this box. [ X ] Item 4 Ownership See Cover Pages, Items 5 through 11 Item 5 Ownership of Five Percent or Less of a Class: If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ]. Item 6 Ownership of More than Five Percent on Behalf of Another Person: Not applicable Item 7 Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company: Not applicable Item 8 Identification and Classification of Members of the Group: Not applicable Item 9 Notice of Dissolution of Group: Not applicable Item 10 Certifications: "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect." Exhibits Joint Filing Agreement, dated February 12, 2001, between the Reporting Persons. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 13, 2001 MEDTRONIC, INC. (Signature) By: /s/ Michael D. Ellwein Vice President and Chief Development Officer MEDTRONIC ASSET MANAGEMENT, INC. By: /s/ Michael D. Ellwein Vice President AGREEMENT TO MAKE A JOINT FILING The undersigned hereby agree to file a joint Schedule 13G with respect to the interests of the undersigned in BioNebraska, Inc. and that the Schedule 13G to which this Agreement is attached has been filed on behalf of each of the undersigned. Date: February 12, 2001 MEDTRONIC, INC. (Signature) By: /s/ Michael D. Ellwein Vice President and Chief Development Officer MEDTRONIC ASSET MANAGEMENT, INC. By: /s/ Michael D. Ellwein Vice President -----END PRIVACY-ENHANCED MESSAGE-----